In cellular assays, FLIN-4 significantly impedes the proliferation of the MV4-11 AML cell line, which carries an exclusive FLT3-ITD mutation, while exerting minimal toxicity on cell lines with FLT3-wildtype and normal hematopoietic cells. Here, FLT3 is linked to acute myeloid leukemia.